Back20/20 Biolabs Common Stock Overview

20/20 Biolabs Common Stock Accounts Payable

Latest accounts payable for AIDX: $980K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$980486.00

Peer average

Loading

20/20 Biolabs Common Stock Accounts Payable History

Loading

20/20 Biolabs Common Stock vs. peers: Accounts Payable Comparison

Loading

20/20 Biolabs Common Stock Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

20/20 Biolabs Common Stock (AIDX) FAQ

As of the most recent data (March 2026), AIDX shows a accounts payable of $980K. Scroll down for historical charts and peer comparison views.

Tracking AIDX's accounts payable over time shows whether 20/20 Biolabs Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $980K Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has 20/20 Biolabs Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $980K) with ownership activity and broader fundamentals.